Patents


Exclusive LifeVantage U.S. Patents

Protandim is protected by four patents. Its patents protect the product from patent infringement--another party duplicating its formula and then creating and marketing an identical product. Every time a new patent is issued, Protandim, The Nrf2 Synergizer, is protected for an extended and additional period of time.

These patents makes the distribution of Protandim, the most potent commercially available Nrf2 synergizing supplement on the market, an exclusive privilege of our independent distributors.

Protandim is protected by 4 U.S. patents:


1st Patent 
Patent No. 7,241,461 was granted July 10, 2007. "Compositions And Methods For Alleviating Inflammation And Oxidative Stress In A Mammal." This is a composition patent.  # 7,241,461 

2nd Patent

Patent No. 7,384,655 was granted June 10, 2008. "Preparation of Compositions to Alleviate Inflammation And Oxidative Stress In A Mammal." This patent is a continuation of the first patent.  # 7,384,655 

3rd Patent

Patent No. 7,579,026 was granted Aug. 25, 2009. "Methods for Enhancing Antioxidant Enzyme Activity And Reducing C-Reactive Protein Levels." This patent is a divisional patent because it addresses method rather than composition.  # 7,579,026 

4th Patent

Patent No. 7,923,045 was granted on April 12, 2011. "Compositions For Alleviating Inflammation And Oxidative Stress In A Mammal." This patent is a continuation of the first patent.  # 7,923,045